Evommune, Inc.

Evommune, Inc. financial statements

Evommune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 13M10-K
Net income−USD 68.87M10-K
Cash and equivalentsUSD 44.06M10-Q
Total debtUSD 1.71MEODHD

Evommune, Inc. financials on 6ix · Evommune, Inc. on 6ix